Peptides Nepal

Posts › Myth or fact? 4 peptide claims Guess before you swipe.

Myth or fact? 4 peptide claims Guess before you swipe.

Myth or fact? 4 peptide claims. Guess before you swipe.
Claim 1: BPC-157 is an approved medicine. MYTH. No health authority has approved it for human use. WADA lists it under S0, non-approved substances.
Claim 2: BPC-157 and TB-500 are banned in tested sport. FACT. WADA bans both at all times: BPC-157 under S0, TB-500 under S2.
Claim 3: Semaglutide and tirzepatide act on the same single hormone receptor. MYTH. Semaglutide acts on GLP-1 receptors. Tirzepatide acts on two: GIP and GLP-1.
Claim 4: Collagen powder is the same as a signal peptide. MYTH. Collagen powder is a food-like mix of protein pieces. Signal peptides are exact molecules that act on receptors.
How many did you get? Comment your score below 👇 Take the full quiz on our website: link in bio Follow @peptidesnepal Education only. Not medical advice.

1. BPC-157 is an approved medicine.
2. BPC-157 and TB-500 are banned in tested sport.
3. Semaglutide and tirzepatide act on the same single receptor.
4. Collagen powder is the same as a signal peptide.

Answers inside. Comment your score: 0/4 to 4/4 👇

🧠 More questions in the full Myth or Fact quiz on our website — link in bio.
📤 Send this to a friend and compare scores.

Follow @peptidesnepal for more info
Visit our website — link in bio for detailed info like this!

Education only — not medical advice.

Sources

Sources 📚
• WADA 2026 Prohibited List — S0 Non-Approved Substances; S2 Peptide Hormones, Growth Factors, Related Substances and Mimetics (wada-ama.org)
• US FDA prescribing information: Wegovy (semaglutide), Zepbound (tirzepatide)
• Virgilio N, et al. Frontiers in Nutrition, 2024;11:1416643 (collagen peptide absorption)

View this post on Instagram →

Related guides

BPC-157 Not approved

A lab-made chain of 15 amino acids, based on part of a protein first found in human stomach juice.

Semaglutide Approved

A GLP-1 receptor agonist: a copy of the gut hormone GLP-1 with a fatty-acid side chain that makes it last about a week.

Tirzepatide Approved

Acts on two gut-hormone receptors: GLP-1 and GIP.